Verastem appoints Michelle Robertson to Board, replacing Gina Consylman effective Nov 15, 2021

Verastem, Inc.

Michelle Robertson appointed as Class III director and audit committee chair, effective Nov 15, 2021.
Gina Consylman resigned from Board and audit committee, effective same date, to focus on other duties.
Robertson is CFO of Editas Medicine; previously CFO of Momenta Pharmaceuticals through J&J acquisition.
Robertson receives stock option grant of 63,493 shares upon joining, plus standard director compensation.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michelle Robertson

Class III Director and Audit Committee Chair

VSTM · Verastem, Inc.

Effective: 2021-11-15
Filed: October 26, 2021, 7:59 PM ET

On October 22, 2021, the Board unanimously voted to elect Ms. Michelle Robertson as a Class III director of the Company and to serve on the audit committee of the Board as chairperson, effective November 15, 2021.

Departed

Gina Consylman

Director

VSTM · Verastem, Inc.

Effective: 2021-11-15
Successor: Michelle Robertson
Filed: October 26, 2021, 7:59 PM ET

On October 21, 2021, Gina Consylman resigned from the Board and its audit committee, effective November 15, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michelle Robertson was elected as Class III Director and Audit Committee Chair at Verastem, Inc..

Action: elected
Role: Class III Director and Audit Committee Chair

Exact text from the filing

On October 22, 2021, the Board unanimously voted to elect Ms. Michelle Robertson as a Class III director of the Company and to serve on the audit committee of the Board as chairperson, effective November 15, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gina Consylman resigned as Director at Verastem, Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 21, 2021, Gina Consylman resigned from the Board and its audit committee, effective November 15, 2021.

View on SEC.gov

Verastem, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-21-013474

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.